ASTH
Astrana Health·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
6.04 / 10Overall Score
OutperformInvestment Rating
6.04 / 10Overall Score
OutperformInvestment Rating
Should I Buy ASTH Now?
- Based on a composite score of 6.04/10, we rate ASTH as a Outperform. Our analysis breaks down into 9.43/10 for Fundamentals, 4.75/10 for Technicals, and 5.00/10 for Sentiment, indicating the stock is likely to See further upside.
What is the current technical signals for ASTH?
Is ASTH fundamentally strong?
What is the market sentiment for ASTH?
Should I Buy ASTH Now?
- Based on a composite score of 6.04/10, we rate ASTH as a Outperform. Our analysis breaks down into 9.43/10 for Fundamentals, 4.75/10 for Technicals, and 5.00/10 for Sentiment, indicating the stock is likely to See further upside.
Is ASTH fundamentally strong?
What is the current technical signals for ASTH?
What is the market sentiment for ASTH?
